Remicade Eases Anxiety, Improves Quality of Life for Some Crohn’s Patients, China Study Finds

Remicade Eases Anxiety, Improves Quality of Life for Some Crohn’s Patients, China Study Finds
Remicade (infliximab) significantly benefitted the mental health of patients newly diagnosed with Crohn’s disease who had responded to the treatment, improving their perceptions of their illness and quality of life, and lowering anxiety levels, a recent study in China showed. These findings were published under the title “Improvement of psychological status after infliximab treatment in patients with newly diagnosed Crohn’s disease” in the journal Patient Preference and Adherence. Crohn’s disease
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *